-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Shenzhen World Life Technology Co.
, Ltd.
(hereinafter referred to as "World Life") announced that it has received 100 million yuan in Series A financing, led by Qiming Venture Capital, followed by Sequoia Capital China Fund
.
This round of financing will be used for the company to deepen the pipeline layout of blood coagulation diagnosis-related products, build a strong marketing team and enhance supply chain capabilities, so that Ward Life's innovative products can serve customers faster and better to benefit patients
Blood coagulation detection is the routine direction of in vitro diagnosis.
Many diseases may cause coagulation disorders, or the occurrence of trauma, pregnancy, cardiovascular, cerebrovascular, and blood diseases caused by coagulation dysfunction
.
Take the cardiovascular direction as an example: According to the statistics of the National Cardiovascular Center of China in 2019, the number of patients with cardiovascular disease in China is as high as 330 million.
References: [1] Venus | Ward Life completed 100 million yuan in Series A financing, Qiming Ventures led the investment.
Retrieved 2021-07-06, from https://mp.
weixin.
qq.
com/s/HMtzUYJLD2_e7bbXdU0aIQ
Retrieved 2021-07-06, from https://mp.
weixin.
qq.
com/s/HMtzUYJLD2_e7bbXdU0aIQ
Note: This article aims to introduce the progress of medical and health research, not to recommend treatment options
.
If you need guidance on treatment plans, please go to a regular hospital for treatment
Note: This article aims to introduce the progress of medical and health research, not to recommend treatment options
Copyright statement: This article is compiled and edited by WuXi AppTec's content team based on public information.
Individuals are welcome to forward it to Moments.
Media or institutions are not allowed to forward/copy to other platforms in any form without authorization
.
For forwarding authorization, please leave a message on the WeChat official account of "Chuangjianhui" to contact us
.